Expand your healthcare
product offering

In the competitive and crowded market, new market entrants or label expansions must show clear clinical differentiation in terms of efficacy and advancement of the standard of care. In addition to their clinical profile, products must also demonstrate value in lowering the overall cost of care. The most successful products build these the product’s value into the design from the earliest stages of development. AplusA is your partner in designing and executing product research.

Expand your healthcare
product offering

In the competitive and crowded market, new market entrants or label expansions must show clear clinical differentiation in terms of efficacy and advancement of the standard of care. In addition to their clinical profile, products must also demonstrate value in lowering the overall cost of care. The most successful products build these the product’s value into the design from the earliest stages of development. AplusA is your partner in designing and executing product research.

MARKET AND CUSTOMER SEGMENTATION

Strategic market and customer segmentation are critical steps in brand planning that allow the marketing team to identify and target collective behaviors and beliefs in purchase/usage decision making. Effective segmentation must:

  • Provide insight into customer requirements and how/why they make purchase/usage decisions,
  • Group customers who share the same or similar value criteria,
  • Enable prioritization of customer segments with the greatest economic potential for the brand
  • Promote the development of targeted marketing, messaging and sales tactics to influence desired customer behaviors.

AplusA’s is your global market and customer segmentation partner, leveraging our expertise in Patient Chart studies and advanced analytical techniques to ensure that you know how to get the right product to the right patient (consumer segmentation) as well as the right message to the right physician (market segmentation).

The AplusA approach identifies meaningful segmentation variables that will guide marketing implementation and enhance actionability.

CLINICAL TRIAL DESIGN EVALUATION

Pressure for healthcare manufacturers to provide real-world evidence for a product’s efficacy and overall value has never been greater. Health insurers and regulatory bodies alike seek to control access to the market to those products who can demonstrate tangible benefits to patients and lower the overall cost of care. Thoughtful design of secondary endpoints as part of your clinical trial plan can provide a solid foundation to make a strong value case for your product.

AplusA is your partner in clinical trial design evaluation. We use a combination of qualitative co-creation and quantitative choice modeling that enables you to:

  • Determine which endpoints are most meaningful to treaters, payers, and regulators.
  • Identify the performance thresholds required to differentiate your product from others on the market and to make a strong case for overall value.
  • Anticipate market access challenges and controls that may impact pricing and reimbursement.

Let’s talk!

Looking to expand your product offering?
Get in touch to discuss a specific project you are working on or to find out more about our services and expertise.